Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Last trade$0.3328
Day change-$0.0472 (-12.42%)
Day range$0.315 – $0.451
Volume685,585
Market cap$17M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$16.71M
Price / earnings
—
Price / book
-2.25×
Price / sales
—
EV / sales
—
EV / EBITDA
-1.69×
Profitability
Earnings per share
-$0.23
Return on assets
-548.74%
Return on equity
134.74%
Dividend yield
0%
Liquidity and leverage
Debt / equity
-0×
Current ratio
0.2×
Quick ratio
0.2×
Cash ratio
0.02×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$9.38M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for ESLA, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Q3 FY2024 Sep 30, 2024
Revenue
$0
$0
$0
$0
$0
$0
$0
$0
Cost of revenue
$0
$0
$0
$0
$0
$0
$0
$0
Gross profit
$0
$0
$0
$0
$0
$0
$0
$0
Selling, general and administrative
$684.02K
$891.79K
$587.79K
$648.51K
$883.73K
$694.11K
$148.68K
$550.74K
Research and development
$1.4M
$1.4M
$25.41K
$4.15M
$4.66M
$1.41M
-$3.52M
$2.83M
Total operating expenses
$2.08M
$2.29M
$613.2K
$4.8M
$5.54M
$2.1M
-$3.37M
$3.38M
Operating income
-$2.08M
-$2.29M
-$613.2K
-$4.8M
-$5.54M
-$2.1M
$3.37M
-$3.38M
Interest expense
$0
$0
$0
$0
$0
$0
$0
$0
Income before taxes
-$2.31M
-$2.29M
-$613.2K
-$4.8M
-$5.54M
-$2.1M
$3.37M
-$3.38M
Income taxes
$0
$0
-$25
$0
$850
$13
-$1.56K
$0
Net income
-$2.31M
-$2.29M
-$613.17K
-$4.8M
-$5.54M
-$2.1M
$3.37M
-$3.38M
Net income attributable to common shareholders
-$2.31M
-$2.29M
-$613.17K
-$4.8M
-$5.54M
-$2.1M
$3.37M
-$3.38M
EBITDA
-$2.08M
-$2.29M
-$613.2K
-$4.8M
-$5.54M
-$2.1M
$3.37M
-$3.38M
Basic earnings per share
-$0.05
-$0.05
-$0.02
-$0.13
-$0.15
-$0.06
$0.09
-$0.09
Diluted earnings per share
-$0.05
-$0.05
-$0.02
-$0.13
-$0.15
-$0.06
$0.09
-$0.09
Recent news
Company coverage with links to the original publishers.
Abbott Cooper PLLC has announced investigations into potential fiduciary duty violations and wrongdoing by the boards of directors of three companies: Abundia Global Impact Group, Inc. (formerly Houston American Energy Corp.), Estrella Immunopharma, Inc., and Stablecoin Development Corporation (formerly NovaBay Pharmaceuticals, Inc.). The law firm is seeking stockholders who held shares continuously since July 1, 2025, or earlier to join the investigations on a contingency fee basis.
Abbott Cooper PLLC is investigating potential fiduciary duty violations and wrongdoing by Estrella Immunopharma's board of directors. The law firm is seeking stockholders to join the investigation on a contingency fee basis.
Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock.
DatChat shares dipped 33.1% to $2.13 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
RiskOn International, Inc. (NASDAQ: ROI) shares rose 51.3% to $0.2250 in pre-market trading.
Meta Materials Inc. (NASDAQ: MMAT) shares jumped 33.2% to $0.0966 in pre-market trading after surging over 20% on Tuesday.
LQR House Inc. (NASDAQ: LQR) gained 25.2% to $2.53 in pre-market trading after dipping 45% on Tuesday. LQR House announced an increase of its share buyback program to $5 million.
Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares climbed 19.3% to $0.1514 in pre-market trading after falling more than 9% on Tuesday.
Zapp Electric Vehicles Group Limited (NASDAQ: ZAPP) shares gained 15.7% to $0.2950 in pre-market trading after dipping 13% on Tuesday.
Solid Power, Inc. (NASDAQ: SLDP) gained 15.1% to $1.37 in pre-market trading. Solid Power deepened its partnership with SK On with three ...
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.